Q3: 2025-10-30 Earnings Summary
EPS of $0.59 beats by $0.14
| Revenue of $260.74M (14.48% Y/Y) misses by $844.75K
Omega Healthcare Investors, Inc. (OHI) Q3 2025 Earnings Call October 31, 2025 10:00 AM EDT
Company Participants
Michele Reber – Senior Director of Asset Management
C. Pickett – CEO & Director
Matthew Gourmand – President
Vikas Gupta – Chief Investment Officer
Robert O. Stephenson – CFO, Treasurer & Assistant Secretary
Megan Krull – Senior Vice President of Operations
Conference Call Participants
Jonathan Hughes – Raymond James & Associates, Inc., Research Division
William John Kilichowski – Wells Fargo Securities, LLC, Research Division
Seth Bergey – Citigroup Inc., Research Division
Juan Sanabria – BMO Capital Markets Equity Research
Omotayo Okusanya – Deutsche Bank AG, Research Division
John Pawlowski – Green Street Advisors, LLC, Research Division
Farrell Granath – BofA Securities, Research Division
Wesley Golladay – Robert W. Baird & Co. Incorporated, Research Division
Michael Carroll – RBC Capital Markets, Research Division
Richard Anderson – Cantor Fitzgerald & Co., Research Division
Vikram Malhotra – Mizuho Securities USA LLC, Research Division
Presentation
Operator
Ladies and gentlemen, thank you for standing by. My name is Desiree, and I will be your conference operator today. At this time, I would like to welcome everyone to the Omega Healthcare Investors Inc. Third Quarter Earnings Conference Call. [Operator Instructions] I would now like to turn the conference over to Michele Reber. You may begin.
Michele Reber
Senior Director of Asset Management
Thank you, and good morning. With me today is Omega’s CEO, Taylor Pickett; President, Matthew Gourmand; CFO, Bob Stephenson; CIO, Vikas Gupta; and Megan Krull, Senior Vice President of Operations. Comments made during this conference call that are not historical facts may be forward-looking statements, such as statements regarding our financial projections, potential transactions, operator prospects and outlook generally.
Factors that could cause actual results to differ materially from those in the forward-looking statements are detailed in the company’s filings with the SEC. During the call today, we will refer to some
Read the full article here







